What is Neural Tube Defects?
Neural tube defects (NTDs) are a group of birth defects that occur when the neural tube – the embryonic precursor to the brain and spinal cord – fails to close completely during the first 3–4 weeks of pregnancy. The two most common NTDs are:
- Spina bifida – incomplete closure of the spinal column, often leaving the spinal cord exposed.
- Anencephaly – severe under‑development of the brain and skull; the baby is usually stillborn or dies shortly after birth.
Less common NTDs include encephalocele (a protrusion of brain tissue through an opening in the skull) and in‑utero fetal paralysis caused by spinal cord damage. NTDs affect roughly 1 in 1,000 live births in the United States, but incidence varies worldwide, largely reflecting differences in nutrition and genetics [1].
Common Causes
Most NTDs result from a combination of genetic susceptibility and environmental factors. Below are the most frequently cited contributors:
- Folate (Vitamin B9) deficiency – inadequate maternal folate before conception and during early pregnancy is the single greatest modifiable risk factor.
- Genetic mutations – variants in genes such as MTHFR, TCN2, and those involved in folate metabolism increase risk.
- Maternal diabetes – poorly controlled pre‑gestational diabetes raises the odds of NTDs 3–4‑fold.
- Obesity – body‑mass index (BMI) ≥ 30 kg/m² is associated with higher NTD rates, possibly through altered folate metabolism.
- Antiepileptic drugs (AEDs) – especially valproic acid, carbamazepine, and phenytoin, which interfere with folate pathways.
- Exposure to teratogenic substances – alcohol, certain pesticides, and high‑dose vitamin A (retinoids).
- Maternal hyperthermia – fever > 102 °F (38.9 °C) in the first trimester has been linked to neural tube malformations.
- Low socioeconomic status – often correlates with poor nutrition, limited access to prenatal care, and higher prevalence of the above risk factors.
- Previous pregnancy with an NTD – recurrence risk is about 2–5 % without preventive measures.
- Certain infections – maternal rubella or cytomegalovirus infection during early gestation can disrupt neural tube closure.
Associated Symptoms
The clinical picture depends on the specific type and severity of the defect. Commonly reported findings include:
- Visible sac or “meningocele” on the lower back (spina bifida occulta or meningomyelocele).
- Weakness or paralysis of the legs, loss of sensation, and abnormal reflexes.
- Bladder or bowel dysfunction (incontinence, constipation).
- Hydrocephalus – accumulation of cerebrospinal fluid causing an enlarged head, often seen with myelomeningocele.
- Seizures or developmental delay, especially when brain tissue is involved (anencephaly, encephalocele).
- Orthopedic problems such as clubfoot or scoliosis.
- Skin changes over the defect: a tuft of hair, dimpling, or a birthmark.
- In severe cases (anencephaly), lack of brainstem function resulting in absent breathing drive.
When to See a Doctor
Prompt evaluation is crucial. Seek medical care if you notice any of the following during pregnancy or after birth:
- Any abnormal swelling, fluid‑filled sac, or birthmark on the baby’s back or skull.
- Reduced movement of the fetus on ultrasound or a “lemon sign”/“banana sign” on prenatal imaging.
- New‑onset urinary retention or incontinence in an infant.
- Weakness, numbness, or loss of coordination in a newborn or young child.
- Signs of increased intracranial pressure – bulging fontanelle, rapid head growth, vomiting.
- History of risk factors (e.g., maternal diabetes, antiepileptic drug use) without appropriate folic‑acid supplementation.
Diagnosis
Diagnosis relies on a combination of prenatal screening, imaging, and post‑natal assessment:
Prenatal Screening
- Maternal serum alpha‑fetoprotein (AFP) – elevated levels at 16–18 weeks suggest an open NTD.
- Ultrasound – high‑resolution transabdominal or transvaginal scanning can visualize the defect, identify associated hydrocephalus, and guide prognosis.
- Amniocentesis – measurement of AFP and acetylcholinesterase in amniotic fluid confirms open NTDs; fetal karyotyping can assess for chromosomal anomalies.
Post‑natal Evaluation
- Physical examination – inspection of the spine/skull, neurological assessment, and skin markers.
- Imaging – MRI is the gold standard for detailing spinal cord involvement; CT scan can delineate bony defects.
- Neurological testing – electromyography (EMG) and nerve‑conduction studies help quantify motor deficits.
- Urologic studies – renal ultrasound and urodynamic testing assess bladder function.
- Genetic counseling – recommended for families with a prior NTD or known genetic risk.
Treatment Options
Treatment is individualized, focusing on correcting the defect, preventing complications, and maximizing functional independence.
Surgical Interventions
- In‑utero repair (fetoscopic or open surgery) – performed before 26 weeks for myelomeningocele; reduces need for shunting and improves motor outcomes [2].
- Post‑natal closure – within 48 hours of birth for open spina bifida to reduce infection risk.
- Hydrocephalus management – ventriculoperitoneal (VP) shunt placement or endoscopic third ventriculostomy.
- Orthopedic procedures – tendon releases, spinal fusion, or corrective bracing for scoliosis or clubfoot.
Medical & Supportive Care
- Folic acid supplementation – 4 mg/day for high‑risk mothers (previous NTD pregnancy, diabetes, or AED use).
- Seizure control – if epilepsy is present, choose low‑risk AEDs (e.g., lamotrigine).
- Neuro‑rehabilitation – physical therapy, occupational therapy, and speech therapy to promote development.
- Urologic care – clean intermittent catheterization and prophylactic antibiotics to prevent urinary infections.
- Psychosocial support – counseling for families, connection with support groups (e.g., Spina Bifida Association).
Home Management
- Maintain skin integrity over any residual sac – keep the area clean, dry, and protected.
- Monitor bladder habits; report any change in urine output or infections promptly.
- Encourage age‑appropriate activity while avoiding high‑impact injuries that could damage the spine.
- Adhere to prescribed vitamin regimens and scheduled follow‑up appointments.
Prevention Tips
Because many NTDs are preventable through public‑health measures, the following strategies are strongly recommended:
- Take daily folic acid – 400 µg for all women of childbearing age; 4 mg for those with known risk factors. Start at least one month before conception and continue through the first trimester [3].
- Adopt a folate‑rich diet – leafy greens, legumes, fortified cereals, and citrus fruits complement supplementation.
- Control pre‑existing diabetes – achieve HbA1c < 6.5 % before pregnancy; work closely with an endocrinologist.
- Maintain a healthy weight – aim for BMI < 25 kg/m² before conception.
- Review medications – discuss any antiepileptic or other teratogenic drugs with a healthcare provider; consider switching to safer alternatives when possible.
- Avoid alcohol and smoking – both increase the risk of neural tube malformations.
- Get vaccinated – rubella immunity protects against infection that can affect neural tube development.
- Seek early prenatal care – first‑trimester visits allow timely AFP screening and ultrasound.
- Family planning counseling – especially after a child with an NTD, to discuss recurrence risk and preventive folic acid dosing.
Emergency Warning Signs
- Sudden swelling or fluid‑filled bulge on a newborn’s back or head.
- Rapid increase in head circumference or bulging fontanelle (possible hydrocephalus).
- Loss of bladder or bowel control after a period of normal function.
- New weakness, numbness, or paralysis in the legs.
- Persistent vomiting, especially when coupled with lethargy or seizures.
- Fever > 101 °F (38.3 °C) in a newborn with a known spinal defect – risk of meningitis.
- Any sign of infection at the surgical site (redness, drainage, increasing pain).
If any of these occur, seek emergency medical care immediately.
References:
- CDC. Neural Tube Defects (NTDs). https://www.cdc.gov. Accessed May 2026.
- MOMS Trial Investigators. "A Randomized Trial of Prenatal Versus Postnatal Repair of Myelomeningocele." N Engl J Med. 2011;364:993‑1004.
- Mayo Clinic. "Folic Acid: How Much Do You Need?" https://www.mayoclinic.org. Accessed May 2026.
- World Health Organization. "Guidelines on Prevention of Neural Tube Defects." WHO Publication, 2022.